Investigators identified two major intrinsic genomic subtypes, G-INT and G-DIF, that were predictive of survival, but subtypes based on Lauren’s histopathology were not.
Compared with G-DIF cell lines, G-INT cell lines were more resistant to cisplatin and significantly more sensitive to 5-FU and oxaliplatin. Intrinsic subtypes were correlated with patient survival time following adjuvant 5-FU therapy.
Read the Gastroenterology report linking gastric cancer subtypes to survival.
Related Articles on Gastric Cancer:
Study: White Light Endoscopy With Narrow-Band Imaging Shows Promise
75 of the Best Gastroenterologists in America
Study: More Frequent Colonoscopies Suggested for Families With Lynch Syndrome
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
